Use the Search Fields to Find Information
Page 12 of 379
Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder
Abstract Posttraumatic stress disorder is often treatment-resistant and recent research has suggested that treatment outcomes might be improved by modulation of the endocannabinoid system. The
May 17, 2026
Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease
Abstract Alzheimer’s disease (AD), the most common neurodegenerative disease, is characterized by progressive cognitive impairment. The deposition of amyloid beta (Aβ) and hyperphosphorylated tau is
April 19, 2024
Understanding Older Adults’ Experiences with Cannabis for Medicinal Purposes: A Mixed Methods Study
Abstract The aim of this study was to explore the perspectives of older medicinal cannabis consumers and those advising them on older Canadians’ experiences accessing
April 17, 2025
Understanding cancer survivors’ reasons to medicate with cannabis: A qualitative study based on the theory of planned behavior
Abstract Background Prior to nonmedical cannabis legalization in Canada, individuals were only able to access cannabis legally through licensed producers with medical authorization. Now with
June 13, 2025
Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome
Fragile X syndrome, the most commonly known genetic cause of autism, is due to loss of the fragile X mental retardation protein, which regulates signal
September 19, 2019
UK Medical Cannabis Registry: Assessment of clinical outcomes in patients with insomnia
Abstract Introduction The primary aim of this study was to assess changes in sleep-specific health-related quality of life (HRQoL) for those prescribed cannabis-based medicinal products
December 17, 2024
UK medical cannabis registry: assessment of clinical outcomes in patients with headache disorders
ABSTRACT Objectives Headache disorders are a common cause of disability and reduced health-related quality of life globally. Growing evidence supports the use of cannabis-based medicinal
October 3, 2024
UK medical cannabis registry: an updated clinical outcomes analysis of patients with post-traumatic stress disorder
ABSTRACT Background Cannabis-based medicinal products (CBMPs) are a potential treatment for post-traumatic stress disorder (PTSD), but their long-term efficacy and safety need further investigation. This
January 25, 2026
UK medical cannabis registry: an updated analysis of clinical outcomes of cannabis-based medicinal products for inflammatory bowel disease
ABSTRACT Background Treatments for inflammatory bowel disease (IBD) remain limited, and cannabis-based medicinal products (CBMPs) provide promise in addressing inflammation and pain. However, long-term data
February 27, 2025
Page 12 of 379